Tigelast-50 Injection

Tigecycline 50 mg Injection (Lyophilised) — MDR Antibiotic

Tigelast-50 Injection — Tigecycline 50 mg (Lyophilised) from Trumac Healthcare PCD Pharma Franchise India

Composition Tigecycline 50 mg (Lyophilised)
Dosage Form Injection (Vial)
Pack Type Lyophilised Vial + Diluent
Pack Size 1 Vial Pack
MRP ₹ 3420
Therapy Critical Care / ICU — Glycylcycline (MDR Antibiotic)
Storage Store between 2–25 °C, protect from light. Use immediately after reconstitution.

📱 WhatsApp Enquiry📞 Call: +919041677932

About Tigelast-50 Injection

Tigelast-50 Injection delivers Tigecycline 50 mg IV — reserve antibiotic for complicated intra-abdominal infections, complicated SSTIs, and CABP caused by MDR organisms. FDA boxed warning for increased mortality — use only when alternatives unavailable.

Manufactured by Trumac Healthcare under WHO-GMP.

Indications

  • Complicated intra-abdominal infections (MDR)
  • Complicated SSTIs (MDR)
  • Community-acquired bacterial pneumonia (MDR)
  • MDR/XDR Acinetobacter (off-label)

Mechanism of Action

Tigecycline is a glycylcycline antibiotic — broad-spectrum activity including MRSA, VRE, ESBL-producing Enterobacteriaceae, multi-drug-resistant Acinetobacter. Reserve antibiotic for complicated infections.

Dosage & Administration

Adults: 100 mg loading then 50 mg every 12 hours IV.

Side Effects

Severe nausea/vomiting (very common — often dose-limiting), increased all-cause mortality (FDA boxed warning — use only when no alternatives), hepatic enzyme elevation.

Contraindications & Precautions

Pregnancy, children below 18 (tooth discolouration), severe hepatic impairment, hypersensitivity to tetracyclines.

Storage

Store between 2–25 °C, protect from light. Use immediately after reconstitution.

PCD Pharma Franchise & Third-Party Manufacturing
Tigelast-50 Injection is available for monopoly-based PCD pharma franchise across India and for third-party manufacturing under your brand. WHO-GMP certified, with full visual-aid and promotional support. Become a Trumac franchise partner →

Frequently Asked Questions

What is Tigelast-50 Injection used for?

Tigelast-50 Injection contains Tigecycline 50 mg (Lyophilised). Used as per the indications described above.

How should Tigelast-50 Injection be taken?

As directed by your physician. Complete the prescribed course.

Is Tigelast-50 Injection available for PCD pharma franchise?

Yes, Trumac Healthcare offers Tigelast-50 Injection on monopoly-based PCD pharma franchise and for third-party manufacturing.

How should Tigelast-50 Injection be stored?

Store below 30 °C in a dry place, protected from light and moisture.

Is Tigelast-50 Injection WHO-GMP certified?

Yes, manufactured in WHO-GMP and DCGI-compliant facilities.

Related Products

B2B Disclaimer: This page is part of a Business-to-Business (B2B) pharmaceutical catalog intended for distributors, PCD franchise partners and healthcare professionals. Information provided is for commercial and educational reference only. Not for consumer sale. Patients must not self-medicate; please consult a qualified medical practitioner. All trade inquiries are subject to valid Drug License and GST documentation.